If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...

Wegovy (semaglutide) is a GLP-1 receptor agonist that’s ... In a year-long study funded by Saxenda’s manufacturer, Novo Nordisk, people without diabetes who took Saxenda lost an average of 18 pounds.

A Scandinavian economic behemoth, Novo Nordisk is the highest valued company in Europe at over $500 billion, which exceeds ...

Ozempic, Mounjaro, Wegovy, Victoza and Trulicity are part of a class of ... consultation with a healthcare professional and ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

While semaglutide remains on the shortage list, Novo Nordisk noted last week that the last remaining dose in short supply — the lowest dose of Wegovy — is now listed as available, CNN reported. “We’re ...

You might well think that it sounds too good to be true - a pill that means you can enjoy alcohol without suffering any ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...